AAPL343.01-0.90 (-0.26%) ▼|ABBV286.49-0.37 (-0.13%) ▼|ABT103.75-1.13 (-1.08%) ▼|ACN237.94-9.29 (-3.76%) ▼|ADBE251.84-6.78 (-2.62%) ▼|AMAT387.39-0.21 (-0.05%) ▼|AMD546.64+15.36 (+2.89%) ▲|AMGN445.45+0.82 (+0.18%) ▲|AMT187.21-1.08 (-0.57%) ▼|AMZN249.64+0.55 (+0.22%) ▲|AVGO337.32+8.15 (+2.48%) ▲|AXP313.64-1.41 (-0.45%) ▼|BA185.35-2.96 (-1.57%) ▼|BAC50.66+0.14 (+0.27%) ▲|BKNG151.00-2.14 (-1.40%) ▼|BLK1,131.08+3.42 (+0.30%) ▲|BMY61.33-0.28 (-0.45%) ▼|BNY147.54+0.36 (+0.24%) ▲|BRK-B544.92-3.64 (-0.66%) ▼|C122.83+1.79 (+1.48%) ▲|CAT703.11+10.98 (+1.59%) ▲|CL92.53-0.58 (-0.62%) ▼|CMCSA22.00-0.05 (-0.23%) ▼|COF202.51+0.16 (+0.08%) ▲|COP149.88-1.49 (-0.98%) ▼|COST997.30-7.86 (-0.78%) ▼|CRM242.68-4.93 (-1.99%) ▼|CSCO110.34+0.10 (+0.09%) ▲|CVS92.46-0.07 (-0.08%) ▼|CVX230.49-1.52 (-0.66%) ▼|DE650.76+9.51 (+1.48%) ▲|DHR231.87-1.10 (-0.47%) ▼|DIS109.83-0.57 (-0.52%) ▼|DUK124.33-0.11 (-0.09%) ▼|EMR163.10+1.40 (+0.87%) ▲|FDX304.14+3.56 (+1.18%) ▲|GD355.79-1.25 (-0.35%) ▼|GE293.40+4.97 (+1.72%) ▲|GEV874.06+19.44 (+2.27%) ▲|GILD157.38-1.31 (-0.83%) ▼|GM80.10+3.79 (+4.96%) ▲|GOOG314.70+0.51 (+0.16%) ▲|GOOGL318.22+1.42 (+0.45%) ▲|GS911.06+17.78 (+1.99%) ▲|HD317.96-1.43 (-0.45%) ▼|HON217.21-2.07 (-0.94%) ▼|IBM250.80-2.64 (-1.04%) ▼|INTC92.22+1.75 (+1.93%) ▲|INTU330.60-9.29 (-2.73%) ▼|ISRG449.42-2.21 (-0.49%) ▼|JNJ267.30+1.00 (+0.38%) ▲|JPM336.32+2.28 (+0.68%) ▲|KO92.66-0.04 (-0.04%) ▼|LIN507.34-0.22 (-0.04%) ▼|LLY1,286.81+7.67 (+0.60%) ▲|LMT631.64-3.56 (-0.56%) ▼|LOW196.11-2.12 (-1.07%) ▼|LRCX237.11-0.40 (-0.17%) ▼|MA607.87-5.63 (-0.92%) ▼|MCD248.95-1.88 (-0.75%) ▼|MDLZ62.44-0.53 (-0.84%) ▼|MDT94.11-0.68 (-0.72%) ▼|META621.64-8.92 (-1.41%) ▼|MMM172.09-0.70 (-0.41%) ▼|MO73.20-0.43 (-0.58%) ▼|MRK140.82+0.21 (+0.15%) ▲|MS186.22+2.73 (+1.49%) ▲|MSFT528.97-3.63 (-0.68%) ▼|MU914.58+10.88 (+1.20%) ▲|NEE82.20+0.16 (+0.20%) ▲|NFLX63.06-0.85 (-1.32%) ▼|NKE37.74-0.17 (-0.45%) ▼|NOW154.24-3.94 (-2.49%) ▼|NVDA215.85-0.15 (-0.07%) ▼|ORCL129.92+3.86 (+3.06%) ▲|PEP134.52-0.94 (-0.69%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG159.07-0.86 (-0.53%) ▼|PLTR197.40-1.44 (-0.72%) ▼|PM203.35+1.48 (+0.73%) ▲|QCOM179.64+0.04 (+0.02%) ▲|RTX196.97-0.52 (-0.26%) ▼|SBUX101.44-1.26 (-1.22%) ▼|SCHW89.59-0.14 (-0.16%) ▼|SO91.96-0.62 (-0.66%) ▼|SPG211.59-1.10 (-0.52%) ▼|T20.95+0.10 (+0.46%) ▲|TMO688.36+3.47 (+0.51%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA401.33+9.71 (+2.48%) ▲|TXN302.37+4.25 (+1.43%) ▲|UBER65.67-0.46 (-0.70%) ▼|UNH411.41+0.71 (+0.17%) ▲|UNP296.79-0.18 (-0.06%) ▼|UPS103.16+2.84 (+2.83%) ▲|USB59.23-0.48 (-0.80%) ▼|V399.42-4.74 (-1.17%) ▼|VZ43.27+0.17 (+0.39%) ▲|WFC82.30-0.36 (-0.43%) ▼|WMT119.23-1.06 (-0.88%) ▼|XOM182.01-2.53 (-1.37%) ▼|AAPL343.01-0.90 (-0.26%) ▼|ABBV286.49-0.37 (-0.13%) ▼|ABT103.75-1.13 (-1.08%) ▼|ACN237.94-9.29 (-3.76%) ▼|ADBE251.84-6.78 (-2.62%) ▼|AMAT387.39-0.21 (-0.05%) ▼|AMD546.64+15.36 (+2.89%) ▲|AMGN445.45+0.82 (+0.18%) ▲|AMT187.21-1.08 (-0.57%) ▼|AMZN249.64+0.55 (+0.22%) ▲|AVGO337.32+8.15 (+2.48%) ▲|AXP313.64-1.41 (-0.45%) ▼|BA185.35-2.96 (-1.57%) ▼|BAC50.66+0.14 (+0.27%) ▲|BKNG151.00-2.14 (-1.40%) ▼|BLK1,131.08+3.42 (+0.30%) ▲|BMY61.33-0.28 (-0.45%) ▼|BNY147.54+0.36 (+0.24%) ▲|BRK-B544.92-3.64 (-0.66%) ▼|C122.83+1.79 (+1.48%) ▲|CAT703.11+10.98 (+1.59%) ▲|CL92.53-0.58 (-0.62%) ▼|CMCSA22.00-0.05 (-0.23%) ▼|COF202.51+0.16 (+0.08%) ▲|COP149.88-1.49 (-0.98%) ▼|COST997.30-7.86 (-0.78%) ▼|CRM242.68-4.93 (-1.99%) ▼|CSCO110.34+0.10 (+0.09%) ▲|CVS92.46-0.07 (-0.08%) ▼|CVX230.49-1.52 (-0.66%) ▼|DE650.76+9.51 (+1.48%) ▲|DHR231.87-1.10 (-0.47%) ▼|DIS109.83-0.57 (-0.52%) ▼|DUK124.33-0.11 (-0.09%) ▼|EMR163.10+1.40 (+0.87%) ▲|FDX304.14+3.56 (+1.18%) ▲|GD355.79-1.25 (-0.35%) ▼|GE293.40+4.97 (+1.72%) ▲|GEV874.06+19.44 (+2.27%) ▲|GILD157.38-1.31 (-0.83%) ▼|GM80.10+3.79 (+4.96%) ▲|GOOG314.70+0.51 (+0.16%) ▲|GOOGL318.22+1.42 (+0.45%) ▲|GS911.06+17.78 (+1.99%) ▲|HD317.96-1.43 (-0.45%) ▼|HON217.21-2.07 (-0.94%) ▼|IBM250.80-2.64 (-1.04%) ▼|INTC92.22+1.75 (+1.93%) ▲|INTU330.60-9.29 (-2.73%) ▼|ISRG449.42-2.21 (-0.49%) ▼|JNJ267.30+1.00 (+0.38%) ▲|JPM336.32+2.28 (+0.68%) ▲|KO92.66-0.04 (-0.04%) ▼|LIN507.34-0.22 (-0.04%) ▼|LLY1,286.81+7.67 (+0.60%) ▲|LMT631.64-3.56 (-0.56%) ▼|LOW196.11-2.12 (-1.07%) ▼|LRCX237.11-0.40 (-0.17%) ▼|MA607.87-5.63 (-0.92%) ▼|MCD248.95-1.88 (-0.75%) ▼|MDLZ62.44-0.53 (-0.84%) ▼|MDT94.11-0.68 (-0.72%) ▼|META621.64-8.92 (-1.41%) ▼|MMM172.09-0.70 (-0.41%) ▼|MO73.20-0.43 (-0.58%) ▼|MRK140.82+0.21 (+0.15%) ▲|MS186.22+2.73 (+1.49%) ▲|MSFT528.97-3.63 (-0.68%) ▼|MU914.58+10.88 (+1.20%) ▲|NEE82.20+0.16 (+0.20%) ▲|NFLX63.06-0.85 (-1.32%) ▼|NKE37.74-0.17 (-0.45%) ▼|NOW154.24-3.94 (-2.49%) ▼|NVDA215.85-0.15 (-0.07%) ▼|ORCL129.92+3.86 (+3.06%) ▲|PEP134.52-0.94 (-0.69%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG159.07-0.86 (-0.53%) ▼|PLTR197.40-1.44 (-0.72%) ▼|PM203.35+1.48 (+0.73%) ▲|QCOM179.64+0.04 (+0.02%) ▲|RTX196.97-0.52 (-0.26%) ▼|SBUX101.44-1.26 (-1.22%) ▼|SCHW89.59-0.14 (-0.16%) ▼|SO91.96-0.62 (-0.66%) ▼|SPG211.59-1.10 (-0.52%) ▼|T20.95+0.10 (+0.46%) ▲|TMO688.36+3.47 (+0.51%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA401.33+9.71 (+2.48%) ▲|TXN302.37+4.25 (+1.43%) ▲|UBER65.67-0.46 (-0.70%) ▼|UNH411.41+0.71 (+0.17%) ▲|UNP296.79-0.18 (-0.06%) ▼|UPS103.16+2.84 (+2.83%) ▲|USB59.23-0.48 (-0.80%) ▼|V399.42-4.74 (-1.17%) ▼|VZ43.27+0.17 (+0.39%) ▲|WFC82.30-0.36 (-0.43%) ▼|WMT119.23-1.06 (-0.88%) ▼|XOM182.01-2.53 (-1.37%) ▼|
12.3 C
New York
Tuesday, October 27, 2026

Tag: patient

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /CNW/ -- As lawmakers weigh potential cuts to scientific research...

From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 16, 2025 /PRNewswire/ -- Equity Insider News Commentary – Increased usage of AI...

ALIMENTATION COUCHE-TARD ANNOUNCES WITHDRAWAL OF PROPOSAL TO ACQUIRE SEVEN & I HOLDINGS DUE TO LACK OF ENGAGEMENT

Issues Letter to the Board of Directors of Seven & i Holdings Co., Ltd. LAVAL, QC, July 16, 2025 /PRNewswire/ - Alimentation Couche-Tard ("Couche-Tard" or the "Corporation") (TSX:...

ALIMENTATION COUCHE-TARD ANNOUNCES WITHDRAWAL OF PROPOSAL TO ACQUIRE SEVEN & I HOLDINGS DUE TO LACK OF ENGAGEMENT

Issues Letter to the Board of Directors of Seven & i Holdings Co., Ltd. LAVAL, QC, July 16, 2025 /CNW/ - Alimentation Couche-Tard ("Couche-Tard" or the "Corporation") (TSX:...

NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards

Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants.

Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of...

The evolving peanut allergy treatment market landscape features clinical trials led by DBV Technologies (Viaskin Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abello (Sublingual...

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

Universal Technical Institute, Inc. to Hold Fiscal Third Quarter 2025 Conference Call on Wednesday, August 6, 2025, at 4:30 p.m. ET

PHOENIX, July 16, 2025 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI) (the "Company"), a leading workforce education provider for transportation, skilled technicians, electrical,...

Half-Year Report on Liquidity Contract with Invest Securities

Half-Year Report on Liquidity Contract with Invest Securities

Gimme Credit Report Warns of Mounting Headwinds for U.S. Health Insurers Amid Regulatory Scrutiny and Funding Challenges

NEW YORK, July 16, 2025 /PRNewswire/ -- A new report from Gimme Credit's Senior Bond Analyst, Terri Cancelarich highlights growing pressures facing U.S. health...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Sarepta To Contact Him Directly To Discuss Their Options

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient